Значок книги

RIPK2: a promising target for cancer treatment

As an essential mediator of inflammation and innate immunity, the receptor-interacting serine/threonine-protein kinase-2 (RIPK2) is responsible for transducing signaling downstream of the intracellular peptidoglycan sensors nucleotide oligomerization domain (NOD)-like receptors 1 and 2 (NOD1/2), whi...

Полное описание

Сохранить в:

Библиографические подробности
Главные авторы:	Jieqiong You (Автор), Ying Wang (Автор), Haifeng Chen (Автор), Fang Jin (Автор)
Формат:	‌
Опубликовано:	Frontiers Media S.A., 2023-05-01T00:00:00Z.
Предметы:	article
Online-ссылка:	Connect to this object online.
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!

Схожие документы

Metal nanoparticles as a promising technology in targeted cancer treatment
по: Jia-Jie Xu, и др.
Опубликовано: (2022)

WSB1 regulates c-Myc expression through β-catenin signaling and forms a feedforward circuit
по: Xiaomeng Gao, и др.
Опубликовано: (2022)

RIPK2 as a New Therapeutic Target in Inflammatory Bowel Diseases
по: Hajime Honjo, и др.
Опубликовано: (2021)

Initial therapeutic target attainment of perampanel in pediatric patients with epilepsy
по: Lingyan Yu, и др.
Опубликовано: (2023)

Unveiling the role of iPLA2β in neurodegeneration: From molecular mechanisms to advanced therapies
по: Jiabin Liu, и др.
Опубликовано: (2024)

Targeted Delivery of Liposomal Temozolomide Enhanced Anti-Glioblastoma Efficacy through Ultrasound-Mediated Blood-Brain Barrier Opening
по: Zhuqing Song, и др.
Опубликовано: (2021)

Dimethyl fumarate inhibits necroptosis and alleviates systemic inflammatory response syndrome by blocking the RIPK1-RIPK3-MLKL axis
по: Fu-li Shi, и др.
Опубликовано: (2023)

Cyclin-dependent kinases-based synthetic lethality: Evidence, concept, and strategy
по: Kailin Li, и др.
Опубликовано: (2021)

Turning a Targeting β-Catenin/Bcl9 Peptide Inhibitor into a GdOF@Au Core/Shell Nanoflower for Enhancing Immune Response to Cancer Therapy in Combination with Immune Checkpoint Inhibitors
по: Weiming You, и др.
Опубликовано: (2022)

Antidepressant Mechanism of Traditional Chinese Medicine Formula Xiaoyaosan in CUMS-Induced Depressed Mouse Model via RIPK1-RIPK3-MLKL Mediated Necroptosis Based on Network Pharmacology Analysis
по: Zhi-Yi Yan, и др.
Опубликовано: (2021)

High expression of RIPK2 is associated with Taxol resistance in serous ovarian cancer
по: Yuqing Shen, и др.
Опубликовано: (2022)

Recent advances in the development of RIPK2 modulators for the treatment of inflammatory diseases
по: Anh-Tuan Pham, и др.
Опубликовано: (2023)

Rehmannia glutinosa DC.-Lilium lancifolium Thunb. in the treatment of depression: a comprehensive review and perspectives
по: ZongHao Wang, и др.
Опубликовано: (2024)

Time trends and regional variations in prices of anticancer medicines in China
по: Jinwei Zhang, и др.
Опубликовано: (2024)

Expression of MK-1 and RegⅣ and its clinicopathological significances in the benign and malignant lesions of gallbladder
по: Yang Leping, и др.
Опубликовано: (2011)

Tissue-specific down-regulation of RIPK 2 in Mycobacterium leprae-infected nu/nu mice
по: Byoung Chul Kim, и др.
Опубликовано: (2004)

RIPK2-Mediated Autophagy and Negatively Regulated ROS-NLRP3 Inflammasome Signaling in GMCs Stimulated with High Glucose
по: Chenlin Gao, и др.
Опубликовано: (2019)

Advances in RIPK1 kinase inhibitors
по: Lu Chen, и др.
Опубликовано: (2022)

Multi-segment osteotomy with interlocking intramedullary nail fixation in the treatment of lower limb deformity in older children with hypophosphatemic rickets
по: Ming Lu, и др.
Опубликовано: (2024)

Characterization and Comparison of Contrast Imaging Properties of Naturally Isolated and Heterologously Expressed Gas Vesicles
по: Tingting Liu, и др.
Опубликовано: (2024)

Yi-Qi-Jian-Pi Formula Suppresses RIPK1/RIPK3-Complex-Dependent Necroptosis of Hepatocytes Through ROS Signaling and Attenuates Liver Injury in Vivo and in Vitro
по: Feixia Wang, и др.
Опубликовано: (2021)

Inhibition of RIPK1 kinase does not affect diabetes development: β-Cells survive RIPK1 activation
по: Tatiana Takiishi, и др.
Опубликовано: (2023)

RIPK1 and RIPK3 regulate TNFα-induced β-cell death in concert with caspase activity
по: Christopher J. Contreras, и др.
Опубликовано: (2022)

Jiajiejian gel ameliorates thyroid nodules through regulation of thyroid hormones and suppression of the (IL-6, TNF-α, IL-1β)/JAK2/STAT3/VEGF pathway
по: Changlin Wang, и др.
Опубликовано: (2024)

Structure-based development of potent and selective type-II kinase inhibitors of RIPK1
по: Ying Qin, и др.
Опубликовано: (2024)

Identification of key regulatory genes and their working mechanisms in type 1 diabetes
по: Hui Li, и др.
Опубликовано: (2023)

Paediatric cerebral palsy prevalence and high-risk factors in Henan province, Central China
по: Junying Yuan, и др.
Опубликовано: (2018)

MicroRNA-4287 alleviates inflammatory response via targeting RIPK1 in osteoarthritis
по: Mingyang Xia, и др.
Опубликовано: (2022)

Is it time to recommend AUC-based vancomycin therapeutic drug monitoring only? A cross-sectional survey in China
по: Jieqiong Liu, и др.
Опубликовано: (2024)

Physical activity experience of patients with hypertension: a systematic review and synthesis of qualitative literature
по: Qun Li, и др.
Опубликовано: (2024)

Comparative study on anti-HCV testing using plasma, dried plasma spots (DPS), and dried blood spots (DBS)Highlights
по: Jieqiong Ma, и др.
Опубликовано: (2021)

The Attenuation of Trophoblast Invasion Caused by the Downregulation of EZH2 Is Involved in the Pathogenesis of Human Recurrent Miscarriage
по: Shijian Lv, и др.
Опубликовано: (2019)

Dual-Modality Molecular Imaging of Tumor via Quantum Dots-Liposome-Microbubble Complexes
по: Jieqiong Wang, и др.
Опубликовано: (2022)

Erratum: Advances in RIPK1 kinase inhibitors
по: Frontiers Production Office
Опубликовано: (2023)

Network Pharmacology and Data Mining Approach Reveal the Medication Rule of Traditional Chinese Medicine in the Treatment of Premenstrual Syndrome/Premenstrual Dysphoric Disorder
по: Songlin Qu, и др.
Опубликовано: (2022)

The impact of drug shortages on drug prices: evidence from China
по: Shuchen Hu, и др.
Опубликовано: (2023)

Doxorubicin conjugated with a trastuzumab epitope and an MMP-2 sensitive peptide linker for the treatment of HER2-positive breast cancer
по: Yiwen You, и др.
Опубликовано: (2018)

Necrostatin-1 Prevents Ferroptosis in a RIPK1- and IDO-Independent Manner in Hepatocellular Carcinoma
по: Hanna Yuk, и др.
Опубликовано: (2021)

Paired protein kinases PRKCI-RIPK2 promote pancreatic cancer growth and metastasis via enhancing NF-κB/JNK/ERK phosphorylation
по: Juying Jiao, и др.
Опубликовано: (2023)

Periostin as a promising target of therapeutical intervention for colorectal cancer
по: Li Na Song, и др.
Опубликовано: (2014)